Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
about
Surface functionalization of gold nanoparticles using hetero-bifunctional poly(ethylene glycol) spacer for intracellular tracking and deliveryProgresses towards safe and efficient gene therapy vectorsTumor-targeted gene delivery using poly(ethylene glycol)-modified gelatin nanoparticles: in vitro and in vivo studies.DNA release from lipoplexes by anionic lipids: correlation with lipid mesomorphism, interfacial curvature, and membrane fusionA novel micro-linear vector for in vitro and in vivo gene delivery and its application for EBV positive tumorsNonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safetyGenetic modification of hematopoietic stem cells with nonviral systems: past progress and future prospects.Improvement of hydrodynamics-based gene transfer of nonviral DNA targeted to murine hepatocytes.Nonviral delivery vehicles for use in short hairpin RNA-based cancer therapies.Pharmacokinetic considerations regarding non-viral cancer gene therapy.Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection.Viral-based gene delivery and regulated gene expression for targeted cancer therapy.Controlling the kinetics of interferon transgene expression for improved gene therapy.Peptide GE11-Polyethylene Glycol-Polyethylenimine for targeted gene delivery in laryngeal cancer.Minimal doses of a sequence-optimized transgene mediate high-level and long-term EPO expression in vivo: challenging CpG-free gene design.Hepatocyte-targeted gene transfer by combination of vascularly delivered plasmid DNA and in vivo electroporation.Liver lobe and strain difference in gene expression after hydrodynamics-based gene delivery in mice.
P2860
Q25256706-2BD456F5-F541-498B-9E98-82BD37342587Q26781432-F6136083-D6C4-41EA-8DA4-CD6CD1130E34Q34063131-8C76919B-01E7-4120-944B-BC2E429A630EQ34186558-F20025D3-E7BC-4814-868B-2192B11CEEECQ34450601-A18C9FCF-0100-4B11-8010-8A1E6596637CQ34687112-33973469-EAE9-449A-A997-CAB05E1B9276Q36288888-82150879-FA6A-40D3-B6FF-7F5A601943DAQ36731036-F4666FCC-1E90-4F21-A8F1-6ECD4D1442BFQ36752048-F4BBD726-5606-47A5-8A95-13075970F814Q37092309-0A588ECF-22EE-4B45-A307-F4377042969EQ37110938-513AB0C6-8BB0-4756-ADAF-F7C1BF6402FCQ37641366-D57ADEE5-D4EA-4C18-BE50-0B1CDF5D8917Q38044941-7A9B7C57-F37C-477B-BB77-DD2361894A2BQ38871170-8BA81C12-1FCD-487B-8565-55F8B3B5D137Q45864162-CF8FAEE9-E90B-4501-9EDC-E86F9227B83EQ45880236-A3EB9F49-BFE8-44FD-9606-9F9D56F42795Q46848103-1428DE19-C15B-4DCC-B6D5-88BE73C932D2
P2860
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
@ast
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
@en
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
@nl
type
label
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
@ast
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
@en
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
@nl
prefLabel
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
@ast
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
@en
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
@nl
P356
P1476
Nonviral approaches satisfying various requirements for effective in vivo gene therapy.
@en
P2093
Makiya Nishikawa
Mitsuru Hashida
P304
P356
10.1248/BPB.25.275
P577
2002-03-01T00:00:00Z